OUHSC Research News – Monday, October 23, 2023

The project’s Principal Investigator (PI) is required to monitor and manage the DMS Plan, with at least yearly examination and oversight of data sharing and storage at the time of the Research Performance Progress Report (RPPR). To ensure compliance with NIH DMS guidelines, the following language for element 6, Oversight of Data Management and Sharing was developed by the ORA and MUST be included in your DMS Plan:

For more information on NIH DMS Plans, please visit: https://research.ouhsc.edu/research-administration/grants/data-management-and-sharing-plan

Date: October 26, 2023

Location: Faculty Atrium, Bird Health Sciences Library

Open to all OUHSC faculty, students, and staff. Enjoy food, fun, and fellowship! Come for a session or stay for the day!

Additional Information: Please see the attached flyer (NMLM_Event_26OCT2023)

 

 

Date: October 25, 2023; 12:00 p.m. (CDT)

About this Event: Learn critical information about how to protect your invention and your patent rights. This month’s speaker is Dr. Chris Corbett, Director of Intellectual Property for OTC.

Register for Event: https://oklahoma.zoom.us/meeting/register/tJwrf-itrDIvGtx1UXcMXYt3l6-VALa3Uxrz#/registration

Office of Technology Commercialization Website: ou.edu/otc

 

 

Date: November 30 – December 1, 2023

Description: OU Health Stephenson Cancer Center is proud to host the sixth annual in-person 2023 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference on Nov. 30 - Dec. 1, 2023 in Oklahoma City, Oklahoma, USA.

In its sixth year, the END2CANCER conference will start the morning of November 30, 2023 and conclude in the afternoon of December 1, 2023. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside. Topics to be discussed in the planned thematic sessions include Gene, mRNA, and Drug Delivery, Molecular Signaling and Targets for Therapy, Extracellular Vesicles and Tumor Signaling, Tissue Engineering and Biomimetics, Artificial Intelligence and Application in Cancer, Cancer Metabolism, and Immuno-Oncology/Immunotherapy.A special session on "Training and Career Development Grant Opportunities from the NCI" will be presented by the Director of the Center for Cancer Training at the National Cancer Institute, Dr. Oliver Bogler.  
High school, undergraduate, graduate, medical school, dental school, pharmacy, nursing, engineering students and fellows (residents, post-doctoral and clinical fellows), among others working in any area of cancer-related research are invited to register to attend and present their research work during our poster presentations and compete for awards.
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high school and college students, patient advocates, business professionals, educators and technology transfer specialists. 
A special scientific photo session titled "Art of Science in Light of Nanomedicine" will allow participants (research staff, students and fellows) to display their best research as a photo with a catchy non-scientific caption and compete for a prize. 

 

 

This symposium be hosted by the Oklahoma University Norman Campus from December 11^th to 13^th 2023. This leading conference in bioinformatics and computational biology is hosting 4 workshops on next generation sequencing, molecular epidemiology, single cell omics, and systems immunology. The conference will have post-proceedings and extended abstracts published in Springer Lecture Notes in Bioinformatics (LNBI) and selected submissions will be invited to special issues of the Journal of Computational Biology (JCB) or Transactions on Computational Biology and Bioinformatics (TCBB) dedicated to the conference. The conference will have a poster session and a networking event. Highlight talks of published works or research in progress are also welcomed. Please visit the conference website (https://iccabs.cs.ou.edu/) and consider the CFP for more details. A number of student scholarships and 20% discount is offered for OU affiliate faculty and students for registration fees support.

The Blavatnik Family Foundation and the New York Academy of Sciences are accepting nominations for the 2024 Blavatnik National Awards for Young Scientists in three specific categories: 1. Chemical Sciences, 2. Physical Sciences & Engineering, and 3. Life Sciences.  The Foundation’s Awards Program (http://blavatnikawards.org/awards/national-awards/) seeks to honor America’s most innovative young faculty-rank scientists and engineers.  Every year, one Blavatnik National Awards Laureate in each category will receive $250,000 in unrestricted funds, and additional nominees will be recognized as Finalists.  Applicants are asked to submit a CV, Research Summary, Professional Service and DEI Statement, Key Publications and Patents, two external letters of support, and the category selected by 5 p.m. on November 3 to HSCORA@ouhsc.edu.  Applicants will be notified by November 10 regarding the results of the internal competition.  Nominations from OUHSC in response to this announcement are due by November 29.  Please see the attached call for applications for details (OUHSC Announcement Blavatnik National Awards 2023-24).

 

 

The W. M. Keck Foundation is a private foundation supporting fundamental research in two specific areas: 1. science and engineering, and 2. medical research. The Foundation’s Research Program (https://www.wmkeck.org/research-overview/) seeks to benefit humanity by supporting projects that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field.  Applicants are asked to submit a Notice-of-Intent (NOI) by 5 p.m. on November 1, so that a qualified review panel can be convened.  A one-page concept paper and cv should be submitted by 5 p.m. on November 10, stipulating the area of focus: science and engineering, or medical research.  Applicants will be notified by December 15 regarding the results of the internal competition.  Phase I applications to the Keck Foundation are due by 4:30 p.m. PT on May 1, 2024.  Please see the attached call for applications for details (OUHSC Announcement Keck Foundation 2023-24).

 

 

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $75,000 for one year. Guidelines and Application Form are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email  VPR@ouhsc.edu.

 

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

 

Description: The Developmental Research Program within the Route 66 Endometrial Cancer SPORE seeks applications developing bold new ideas in endometrial cancer research. Projects at the pilot stage investigating new treatment or prevention strategies and/or obtaining preliminary data are encouraged to apply.

Link to the Full Announcement: Please see attached (SPORE_DRP_RFP_2023)

 

 

Description: This program is for Early career faculty or established investigators who wish to develop or refocus their careers on translational research in endometrial cancer with emphasis on etiology, prevention, diagnosis, early detection, treatment, endometrial cancer disparities, or population science, and Senior level post-doctoral or clinical fellows who provide a letter from their Department Chair or Division Director stating that candidate will join its faculty by the time of the award.

Link to the Full Announcement: Please see attached (SPORE_CEP_RFP_2023)

 

 

Description: This is a Request for Information (RFI) directed at obtaining input and soliciting interest in a project to identify one or more subgroups of individuals with non-CF bronchiectasis that may be similar to people with CF in their response to therapies addressing the manifestations of bronchiectasis (e.g., antimicrobial, muco-active, or anti-inflammatory therapies). Further, this work seeks to identify viable research outcome measures for therapeutic trials in bronchiectasis that would enroll people with and without CF. Use of both existing data and prospective collection of new data may be needed to fully phenotype and/or test potential outcome measures across populations. The CF Foundation is especially interested in receiving input from those familiar with research in non-CF bronchiectasis or both patient populations. Individuals or groups interested in leading this research are additionally encouraged to submit descriptions of their interest and qualifications as described below. Please consider forwarding or discussing this RFI with local experts in non-CF bronchiectasis who may not be included in the email distribution.

Additional Information and Submitting a Response: All responses must be submitted to https://www.surveymonkey.com/r/PWSRB9R by December 1, 2023.

 

 

Description: The Chan Zuckerberg Initiative (CZI) invites applications for Cycle 3 of the Single-Cell Biology Data Insights RFA. CZI seeks to support projects that will advance the fields of single-cell biology and data science. Projects may include dedicated efforts to democratize access and usability of existing single-cell datasets, demonstrate utility by leveraging existing single-cell datasets to address impactful and challenging biological questions, and develop methods that enable greater biological insight and other major challenges brought forward.

This request for applications is the last of three currently planned cycles, with successful projects receiving 18 months of funding support. Awards are a maximum of $400,000 in total costs for Expanded Projects, and $200,000 in total costs for Focused Projects.